noscript

News and Announcements

Additional Placement Raises $1.0 million for Prescient Therapeutics

  • Published November 26, 2015 11:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

24th November 2015, ASX Announcement

Cancer drug development company Prescient Therapeutics Limited (ASX: PTX) (‘Prescient’, ‘PTX’ or ‘the Company’) advises that following the oversubscribed Share Purchase Plan (‘SPP’), the Company has subsequently raised approximately $1.0million. The Company is completing an additional top up placement of approximately 19.3 million fully paid ordinary shares at $0.054 (5.4 cents) per share, which is the same price as the SPP issue price. Together with the recently completed SPP, PTX has raised approximately $2.0 million, exceeding the Company’s expectations.

PTX expects these funds to provide for efforts to achieve multiple milestones across its clinical programs over the next 12 to 18 months.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now